Clinical Trial Update: Bevacizumab Plus Nab-paclitaxel and Platinum for Immunotherapy-treated Non-squamous Non-small Cell Lung Cancer [NA]

View source ↗

Summary

This clinical trial update outlines a study evaluating bevacizumab in combination with nab-paclitaxel and platinum for metastatic non-squamous non-small cell lu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Nab-paclitaxel (paclitaxel protein-bound)
• Platinum-based chemotherapy (platinum-based chemotherapy)

Snippet

Sponsor: Fudan University | Conditions: Non-small Cell Lung Cancer Metastatic | NA | Status: ACTIVE_NOT_RECRUITING